RespiVert

Acquired by Centocor Ortho Biotech
Developing innovative inhaled therapies for severe respiratory diseases.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

London, UK

Initial Investment

2007
Developing innovative inhaled therapies for severe respiratory diseases.

RespiVert was a drug discovery and development company focused on inhaled therapies for severe respiratory disease. RespiVert was acquired by Centocor Ortho Biotech – a division of Johnson & Johnson.